Articles by Matthew Karpen - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Matthew Karpen

Matthew Karpen


Production Cost Analysis: Economic Analysis as a tool for Process Development: Harvest of a High Cell-Density Fermentation
November 1, 2006

The number of biotechnology-based human therapeutic products in the late-stage pipeline, and the average cost to commercialize a biotech product, have steadily increased. This has required biotech companies to use economic analysis as a tool during process development and for making decisions about process design. Process development efforts now aim to create processes that are economical, as well as optimal and robust.

ADVERTISEMENT

ADVERTISEMENT

Click here